Kapil Sikka

Kapil Sikka

Auto-generated profile, based on publicly available information

Kapil Sikka

Department of Otolaryngology and Head and Neck Surgery, All India Institute of Medical Sciences, New Delhi, India

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2019 in Journal of Robotic Surgery
Verified
Journal Article
Closed access
PDF file
SPSmriti Panda
Smriti Panda
KSKapil Sikka
Kapil Sikka
ATAlok Thakar
Alok Thakar
SSSuresh C. Sharma
Suresh C. Sharma
PKPadmavathi Krishnamurthy
Padmavathi Krishnamurthy

1 October 2021 in International Journal of Pediatric Otorhinolaryngology
Verified
Journal Article
Closed access
ACAswin Chandran
Aswin Chandran
KSKapil Sikka
Kapil Sikka
ATAlok Thakar
Alok Thakar
RLRakesh Lodha
Rakesh Lodha
DID.V.K. Irugu
D.V.K. Irugu
SSSuresh C. Sharma
Suresh C. Sharma

28 May 2021 in Indian Journal of Otolaryngology and Head & Neck Surgery
Verified
Journal Article
Closed access
PDF file
TCTanvi Chaudhary
Tanvi Chaudhary
AKAnupam Kanodia
Anupam Kanodia
HVHitesh Verma
Hitesh Verma
CSChirom Amit Singh
Chirom Amit Singh
AMAshwani Kumar Mishra
Ashwani Kumar Mishra
KSKapil Sikka
Kapil Sikka

31 August 2021 in Emergency Radiology
Verified
Journal Article
Closed access
PDF file
SMSmita Manchanda
Smita Manchanda
KSKapil Semalti
Kapil Semalti
ABAshu Seith Bhalla
Ashu Seith Bhalla
ATAlok Thakar
Alok Thakar
KSKapil Sikka
Kapil Sikka
HVHitesh Verma
Hitesh Verma


14 October 2020 in Indian Journal of Otolaryngology and Head & Neck Surgery
Verified
Journal Article
Open access
PDF file
SPSmriti Panda
Smriti Panda
AMAdil Mohamed
Adil Mohamed
KSKapil Sikka
Kapil Sikka
AKAnupam Kanodia
Anupam Kanodia
PSPirabu Sakthivel
Pirabu Sakthivel
CKChitresh Kumar
Chitresh Kumar
This study endeavours to comprehensively the study the spectrum of ENT manifestations in mild and asymptomatic COVID-19 and observe the natural course of anosmia and dysgeusia consequent to SARS-Cov-2 infection. A prospective cohort study was undertaken at a tertiary care centre in India on admitted patients with RT-PCR proven COVID-19. Patients were included provided the baseline National Early Warning Score (NEWS) was less than 4. Patients were screened for ENT manifestations using a questionnaire at baseline, 7 days, 14 days and 28 days. 225 patients were included in the study. Of these complete data at 4 weeks was available for 210. Out of 145 patients with mild COVID-19 (asymptomatic = 80), ENT manifestations accounted for 66.2% of all symptoms. Smell and taste disturbance had an overall incidence of 20% and 45% of ENT manifestations. Temporal trends of the recovery rate of anosmia and dysgeusia were 53.6% and 66.7% at 2 weeks, respectively. Corresponding rates at 3 weeks were 89.29% and 86.7%, respectively. By the end of 4 weeks 96% of the patients had recovered completely. The incidence of anosmia and dysgeusia in this study parallels the rates reported from other Asian countries, albeit, lower than the rates quoted from the Western Hemisphere. We recommend structured reporting of all ENT manifestations especially smell and taste disturbances to accurately identify individuals infected with SARS-Cov-2.